Valeant Pharmaceuticals International Inc.
featured news
September 4, 2018
News
U.S. High Court Protects Consumers Over International Comity
(September 4, 2018). Comity. The legal principle that political entities (such as states, nations, or courts from different jurisdictions) will mutually recognize each other’s legislative, executive, and judicial acts. The underlying notion is that different jurisdictions will reciprocate each other’s judgments out of deference, mutuality, and respect. (Cornell Law Legal Definition). […]
August 13, 2018
News
Morganti & Co., P.L.C. committed to European-based Investors
(August 10, 2018). Morganti & Co., reminds European-based investors that Morganti & Co., is the European retail-investor shareholders’ North American law firm. With extensive contacts in United States, Caribbean, Central America, and Europe, Morganti & Co., will be in England, Germany, Netherlands, and Panama prior to year-end meeting with clients […]
August 11, 2018
News
Q&A: Disclosure of Internal Investigations
(August 11, 2018). Morganti & Co has received several inquiries from investors as to when companies must disclose internal investigation. The following note is our Firm’s general approach. Question: When does a reporting issue have the affirmative duty to disclose internal investigations? The answer of this question should commence with […]
July 15, 2018
News
A Lesson to Invest in Numbers not Emotions: Concordia International Corporation
(July 15, 2018). Dear Savvy Reader: Before you read any further, please look at the five (5) year chart for Concordia International Corp. (TSX: “CXR”). The Company’s shares were trading over $100 and are now under $1.00. This securities class action arises out of Concordia’s failure to disclose adverse material […]
June 1, 2018
News
MORGANTI & CO. ADDS ASSOCIATE
June 1, 2018. Ian Liverovich has joined Morganti & Co., P.C. as an associate. His focus will be representing institutional and retail investors in claims relating to cross-border commodity, financial market, and securities manipulation. Ian previously worked in Washington, D.C. and articled at DLA Piper (Canada) LLP. INVESTORS’ RIGHTS AGAINST […]
schedule a free consultation
$200M+
In Canadian Settlements
Top 50
ISS SCAS Top 50 (2017-2021)
10+
Years Representing Canadian Investors
12+
Canadian Court Decisions Advancing Investors’ Rights
On the Cutting Edge of the Profession
Legal Intelligencer
53
Years
